Chuo-ku, Japan

Tomoaki Hamada

USPTO Granted Patents = 2 


Average Co-Inventor Count = 14.0

ph-index = 1


Company Filing History:


Years Active: 2022-2024

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Tomoaki Hamada: Innovator in Pharmaceutical Chemistry

Introduction

Tomoaki Hamada is a notable inventor based in Chuo-ku, Japan. He has made significant contributions to the field of pharmaceutical chemistry, particularly through his innovative work on cycloalkane derivatives. With a total of two patents to his name, Hamada's inventions focus on compounds that have potential therapeutic applications.

Latest Patents

Hamada's latest patents include a cycloalkane-1,3-diamine derivative. This invention provides a compound or a pharmaceutically acceptable salt that exhibits an inhibitory action on the interaction between menin and an MLL protein. The compound is represented by a specific formula, where various components are defined in the detailed description. This innovation holds promise for advancing treatments in related medical fields.

Career Highlights

Hamada is currently employed at Daiichi Sankyo Company, Limited, a leading pharmaceutical company. His work there has allowed him to focus on developing new compounds that can address critical health issues. His expertise in the field has positioned him as a valuable asset to his team and the company.

Collaborations

Hamada collaborates with several talented individuals, including Kenji Yoshikawa and Noriyasu Haginoya. These partnerships enhance the research and development process, fostering an environment of innovation and creativity.

Conclusion

Tomoaki Hamada's contributions to pharmaceutical chemistry through his patents demonstrate his commitment to advancing medical science. His work at Daiichi Sankyo Company, Limited, along with his collaborations, highlights the importance of teamwork in driving innovation.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…